Genomic characterisation of Klebsiella michiganensis co-producing OXA-181 and NDM-1 carbapenemases isolated from a cancer patient in uMgungundlovu District, KwaZulu-Natal Province, South Africa by Founou, R C et al.
CORRESPONDENCE
7       January 2019, Vol. 109, No. 1
Genomic characterisation of Klebsiella 
michiganensis co-producing OXA-181 and NDM-1 carbapenemases isolated 
from a cancer patient in uMgungundlovu 
District, KwaZulu-Natal Province, South 
Africa
To the Editor: The emergence and spread of carbapenem-resistant 
Enterobacteriaceae (CRE) is a serious public health concern 
worldwide, especially for hospitalised patients.[1-3] Klebsiella spp. 
are recognised as significant pathogens responsible for serious 
difficult-to-treat nosocomial infections.[1,4] Several reports have 
identified Klebsiella spp. co-producing New Delhi metallo-beta-
lactamase (NDM) and other carbapenemases worldwide.[1,4-7] 
Although NDM-1-producing K. michiganensis was reported in 
clinical samples from the private sector in KwaZulu-Natal Province, 
South Africa (SA),[8] this is the first detection of blaNDM-1 and 
blaOXA-181 in a carriage isolate of K. michiganensis A202R3B6 
(accession no. QKWV00000000). A 59-year-old cancer patient was 
screened at admission and discharge in a surgical ward in a district 
hospital in SA. The patient received cloxacillin 250 mg twice daily 
for 5 days until discharge. Faecal culture was negative at admission 
but revealed carriage of carbapenemase-producing K. michiganensis 
ST 29 (A202R3B6) at discharge.
This isolate was initially identified as K. oxytoca, but genomic 
identification confirmed it to be K. michiganensis. K. michiganensis 
formed part of a bigger study investigating antibiotic-resistant 
bacteria in clinical and carriage samples from patients admitted 
to a district and tertiary hospital in uMgungundlovu District, 
KwaZulu-Natal, SA. The isolate was identified using biochemical 
tests (Rosco Diagnostica, Denmark). Antimicrobial susceptibility 
testing was performed by broth microdilution, and results were 
interpreted according to the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST). Escherichia coli ATCC 25922, 
K.  pneumoniae ATCC 700603 and K. pneumoniae ATCC 51503 
were used as controls.
Whole-genome sequencing (WGS) analysis was performed on a 
MiSeq platform (Illumina, USA) with 100× coverage. The bacterial 
analysis pipeline of GoSeqIt tools was used to annotate and 
identify known acquired antibiotic-resistant genes via ResFinder,[9] 
virulence factors using VirulenceFinder[10] and mobile genetic 
elements through PlasmidFinder.[11] The multi-locus sequence type 
was determined from WGS data.
The final assembly of K. michiganensis ST 29 A202R3B6 contained 
6 499 557 base pairs with 60.87% G+C content. Analysis of WGS 
data revealed that the K. michiganensis harboured several antibiotic 
resistance genes and multidrug resistance efflux pumps (Table 1). 
PlasmidFinder revealed that the genome of K. michiganenesis ST 29 
(A202R3B6) harboured 12 plasmids, and genomic analysis revealed 
that the IncX3 plasmid harboured blaNDM-1 (Table 1).
To the best of our knowledge, the detection of these 
carbapenemases along with several resistance genes in a carriage 
sample is the first reported from SA and suggests that the intestinal 
tract serves as reservoir of resistant bacteria. blaOXA-181 and blaNDM-1 
are commonly detected in E. coli and K. pneumoniae worldwide,[4,7] 
and as such, the concomitant presence of these carbapenemase 
genes in K. michiganensis ST 29 suggests that horizontal gene 
transfer occurs within and between bacterial species. In addition, 
this isolate was not detected on screening at admission but only 
at discharge, suggesting a lack of infection prevention and control 
(IPC) measures at the hospital. Our findings therefore underline 
the importance of routine screening for extended-spectrum beta-
lactamases and/or carbapenemase bacteria upon admission and the 
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need for IPC to be strictly implemented to reduce the dissemination 
of CRE in SA.
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